Background: In the last decade. tremendous changes occurred in the treatment and follow-up of the patients with chronic myeloid leukemia (CML). with continuous update in the close molecular monitoring of treatment for the presence of minimal residual disease. Objectives: The objective of this study was to evaluate the molecular monitoring of patients with CML on tyrosine kinase inhibi... https://www.truvisionhealthftp.com/